Recruiting

RSV with Vaccines

Sponsor:

Duke University

Code:

NCT07158814

Conditions

Fever

Adverse Event Following Immunisation

Eligibility Criteria

Sex: All

Age: 0

Healthy Volunteers: Accepted

Interventions

Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Duke University on 2026-03-16.